These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 18941223

  • 1. A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection.
    Tang C, Yamada H, Shibata K, Muta H, Wajjwalku W, Podack ER, Yoshikai Y.
    J Immunol; 2008 Nov 01; 181(9):6316-27. PubMed ID: 18941223
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.
    Sun X, Yamada H, Shibata K, Muta H, Tani K, Podack ER, Yoshikai Y.
    J Immunol; 2010 Aug 15; 185(4):2222-30. PubMed ID: 20639486
    [Abstract] [Full Text] [Related]

  • 7. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
    Moulton RA, Mashruwala MA, Smith AK, Lindsey DR, Wetsel RA, Haviland DL, Hunter RL, Jagannath C.
    J Leukoc Biol; 2007 Oct 15; 82(4):956-67. PubMed ID: 17675563
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CD30 ligand is a new therapeutic target for central nervous system autoimmunity.
    Shinoda K, Sun X, Oyamada A, Yamada H, Muta H, Podack ER, Kira J, Yoshikai Y.
    J Autoimmun; 2015 Feb 15; 57():14-23. PubMed ID: 25533628
    [Abstract] [Full Text] [Related]

  • 16. PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin.
    Sakai S, Kawamura I, Okazaki T, Tsuchiya K, Uchiyama R, Mitsuyama M.
    Int Immunol; 2010 Dec 15; 22(12):915-25. PubMed ID: 21047981
    [Abstract] [Full Text] [Related]

  • 17. Characterization of lung gamma delta T cells following intranasal infection with Mycobacterium bovis bacillus Calmette-Guérin.
    Dieli F, Ivanyi J, Marsh P, Williams A, Naylor I, Sireci G, Caccamo N, Di Sano C, Salerno A.
    J Immunol; 2003 Jan 01; 170(1):463-9. PubMed ID: 12496432
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals.
    Maggi E, Annunziato F, Manetti R, Biagiotti R, Giudizi MG, Ravina A, Almerigogna F, Boiani N, Alderson M, Romagnani S.
    Immunity; 1995 Aug 01; 3(2):251-5. PubMed ID: 7648397
    [Abstract] [Full Text] [Related]

  • 20. Gamma interferon responses of CD4 and CD8 T-cell subsets are quantitatively different and independent of each other during pulmonary Mycobacterium bovis BCG infection.
    Ngai P, McCormick S, Small C, Zhang X, Zganiacz A, Aoki N, Xing Z.
    Infect Immun; 2007 May 01; 75(5):2244-52. PubMed ID: 17307945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.